LIN SHAO-LEE (CHIEF EXECUTIVE OFFICER) received a stock award from CUE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/7/2026ACC: 0001193125-26-211806
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2026
+982.61K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
982.61K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+327.54K
Price / share
—
Trade value
—
% of position
New position
5/3/2026
0.00→327.54K
Total
Net shares
+327.54K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/3/2026 | A · Award | +327.54K | — | — | New position | 0.00 | 327.54K |
| Total | +327.54K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
655.07K shares
Shares
+655.07K
Strike price
30.42
Held after
655.07K
Exercisable
—
5/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock655.07K shares | 5/3/2026 | A · Award | +655.07K | 30.42 | — | 655.07K |